Ozempic, Wegovy and other GLP-1 drugs have been shown to curb alcoholism, a new study suggests. Researchers explain why ...

Biotech companies are racing to find Ozempic 2.0, hoping for a slice of a multi-billion-dollar industry. A few stand-out ...

Research shows that 1 in 8 adults in the US has used one of the popular GLP-1 medications, most of them trying to manage ...

Over the past year, the question has been coming in from everywhere – from my patients and family members, from colleagues ...

As optimism for GLP-1 receptor agonists for weight loss has grown, so too has their use in children. Currently, liraglutide ...

Scientists from the University of Copenhagen say they have developed a drug that decreases appetite while increasing calorie ...

A registered dietitian reveals nine food that work like weight-loss drugs, helping to curb cravings and suppress your ...

A new study supports the notion that the same mechanisms that help folks lose weight with Ozempic and its kin also work to ...

State Medicaid programs for low-income families are the single biggest source of coverage, giving 31.6 million people access ...

The stocks of companies that make or are developing the new class of weight-loss and diabetes-management drugs were sharply ...

GLP-1 drug shortages, driven by cosmetic and weight loss purposes, result in access disparities among individuals with ...

Only 13 states currently allow Medicaid to cover treatment of obesity using glucagon-like peptide-1 agonist (GLP-1) ...